Cove Street Capital LLC Sells 13,070 Shares of Enovis Co. (NYSE:ENOV)

Cove Street Capital LLC trimmed its holdings in shares of Enovis Co. (NYSE:ENOV - Free Report) by 23.4% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 42,893 shares of the company's stock after selling 13,070 shares during the period. Enovis comprises 2.2% of Cove Street Capital LLC's holdings, making the stock its 18th largest position. Cove Street Capital LLC owned approximately 0.08% of Enovis worth $1,881,000 as of its most recent SEC filing.

Other hedge funds also recently modified their holdings of the company. Amalgamated Bank grew its position in shares of Enovis by 1.0% in the 4th quarter. Amalgamated Bank now owns 25,887 shares of the company's stock valued at $1,136,000 after acquiring an additional 264 shares during the period. Pinnacle Bancorp Inc. grew its holdings in Enovis by 54.5% during the fourth quarter. Pinnacle Bancorp Inc. now owns 850 shares of the company's stock worth $37,000 after purchasing an additional 300 shares during the period. Arizona State Retirement System grew its holdings in Enovis by 2.6% during the fourth quarter. Arizona State Retirement System now owns 16,208 shares of the company's stock worth $711,000 after purchasing an additional 414 shares during the period. UMB Bank n.a. raised its stake in Enovis by 128.2% in the fourth quarter. UMB Bank n.a. now owns 778 shares of the company's stock valued at $34,000 after buying an additional 437 shares during the period. Finally, New York State Teachers Retirement System raised its stake in Enovis by 3.5% in the fourth quarter. New York State Teachers Retirement System now owns 13,538 shares of the company's stock valued at $594,000 after buying an additional 457 shares during the period. Institutional investors own 98.45% of the company's stock.

Wall Street Analyst Weigh In

Separately, Needham & Company LLC reissued a "buy" rating and set a $64.00 target price on shares of Enovis in a report on Wednesday.

Enovis Stock Performance

ENOV stock traded down $1.88 during mid-day trading on Thursday, hitting $35.10. 363,381 shares of the company were exchanged, compared to its average volume of 709,856. Enovis Co. has a 1-year low of $33.85 and a 1-year high of $62.79. The business has a 50 day simple moving average of $41.48 and a 200-day simple moving average of $43.23. The company has a current ratio of 2.27, a quick ratio of 1.12 and a debt-to-equity ratio of 0.40. The stock has a market capitalization of $2.00 billion, a PE ratio of -16.03 and a beta of 2.05.

Enovis (NYSE:ENOV - Get Free Report) last issued its quarterly earnings data on Wednesday, February 26th. The company reported $0.98 EPS for the quarter, beating analysts' consensus estimates of $0.92 by $0.06. The firm had revenue of $560.98 million for the quarter, compared to analyst estimates of $555.14 million. Enovis had a positive return on equity of 4.39% and a negative net margin of 5.95%. On average, equities analysts forecast that Enovis Co. will post 2.79 earnings per share for the current year.

Enovis Company Profile

Enovis Corporation operates as a medical technology company focus on developing clinically differentiated solutions worldwide. It also manufactures and distributes medical devices which are used for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company operates through Prevention and Recovery, and Reconstructive segments.